NECITUMUMAB y avances en el tratamiento de 1ª línea carcinoma de pulmón escamoso - page 20

RTK

Anti-FGFR1-3

AZD4547

Ponatinib

Dovitinib

Nintedanib

DDR2 mutations

Desatinib

PI3K

PIK3CA

mutations

PTEN deletion

AKT1/2/3

overactivation

Developmental

SOX2

amplification /

SOX2

overexpression

DNA repair

PARP

CDK4/6

Palbociclib

Abemaciclib

Buen pronostico

BASALT 1-3

Estudios en Marcha

SEO Version

Warning.

You are currently viewing the SEO version of !text.
It has a number of design and functionality limitations.

We recommend viewing the Flash version or the basic HTML version of this publication.

1...,10,11,12,13,14,15,16,17,18,19 21